Our findings demonstrate that blocking NOX2 effectively prevents obesity-mediated ion channel remodeling and atrial fibrosis by reducing oxidative stress and ROS production in both DIO mice and PA-treated hiPSC-aCMs. Here, CYBB is linked to obesity disorder.